Stay updated on SL-401 Combo With Pomalid/Dex in MM Clinical Trial
Sign up to get notified when there's something new on the SL-401 Combo With Pomalid/Dex in MM Clinical Trial page.

Latest updates to the SL-401 Combo With Pomalid/Dex in MM Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA site-wide NIH transition notice appears above the page, and the footer revision advances from v3.7.1 to v3.7.2. The study area continues to show a 403 error rather than trial details.SummaryDifference1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe footer’s site revision label changed from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check41 days agoChange DetectedThe page now shows a 403 Forbidden error, indicating that access to the study record is blocked. This replaces the normal study content with an access-denied page and the standard site footer.SummaryDifference19%

- Check48 days agoChange DetectedMultiple myeloma was added to the related topics, MedlinePlus Genetics was added as a related topic, and the revision tag was updated from v3.6.6 to v3.7.0.SummaryDifference0.2%

- Check62 days agoChange DetectedAdded Revision: v3.6.6 and removed the related topics block, including Multiple myeloma and MedlinePlus Genetics. This also removed the older Revision: v3.6.5.SummaryDifference0.2%

- Check76 days agoChange DetectedAdded related topics entries: Multiple myeloma and MedlinePlus Genetics to the study record. These additions enhance disease context and provide a link to a patient education resource.SummaryDifference0.2%

Stay in the know with updates to SL-401 Combo With Pomalid/Dex in MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SL-401 Combo With Pomalid/Dex in MM Clinical Trial page.